Renal impairment at presentation in multiple myeloma continues to be associated with poor survival

E-ISSN： 1365-2141|169|6|901-902

ISSN： 0007-1048

Source： BRITISH JOURNAL OF HAEMATOLOGY, Vol.169, Iss.6, 2015-06, pp. : 901-902

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Report of 134 Newly Diagnosed Multiple Myeloma Patients with Renal Impairment

Acta Haematologica, Vol. 135, Iss. 3, 2015-11 ,pp. : 140-145

Karger

Access to resources Recommend Favorite

Recombinant Human Erythropoietin Is Associated with Increased Overall Survival in Patients with Multiple Myeloma

Acta Haematologica, Vol. 117, Iss. 3, 2006-12 ,pp. : 162-167

Karger

Access to resources Recommend Favorite

Myeloma Renal Disease: Presentation and Outcome

Nephron Clin Pract, Vol. 104, Iss. 3, 2006-07 ,pp. : c126-c131

Karger

Access to resources Recommend Favorite

A Systematic Review on the Use of Bortezomib in Multiple Myeloma Patients with Renal Impairment: What Is the Published Evidence?

Acta Haematologica, Vol. 126, Iss. 3, 2011-07 ,pp. : 163-168

Karger

Access to resources Recommend Favorite

Bortezomib and Dexamethasone in Previously Untreated Multiple Myeloma Associated with Renal Failure and Reversal of Renal Failure

Acta Haematologica, Vol. 116, Iss. 4, 2006-11 ,pp. : 255-258

Karger

Access to resources Recommend Favorite